CD4 and myositis disease: In another patient with nivolumab-related MG/myositis, peripheral blood lymphocyte analysis showed an elevated CD8:CD4 ratio of 1.4 [37], these findings can possibly be related to the activity of nivolumab regardless of induction of MG.